Wedbush Securities’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-13,600
Closed -$25K 1058
2022
Q2
$25K Hold
13,600
﹤0.01% 1054
2022
Q1
$44K Hold
13,600
﹤0.01% 1079
2021
Q4
$58K Buy
+13,600
New +$73.6K ﹤0.01% 1153

Other funds holding CGEN

Wedbush Securities's CGEN Position: Q3 2022 in Review

Wedbush Securities sold out of Compugen (CGEN) in Q3 2022, closing a stake of 13,600 shares — an estimated $25K sold.

Wedbush Securities first reported a position in CGEN in Q4 2021 and held it in 3 quarters. The position peaked at $58K in Q4 2021. 81 funds tracked by Wall St. Rank hold CGEN as of Q3 2022.

  • Wedbush Securities reported no remaining Compugen position as of Q3 2022 after selling out during the quarter.
  • Wedbush Securities sold 13,600 Compugen shares in Q3 2022, an estimated $25K.
  • Wedbush Securities first reported a position in Compugen in Q4 2021 and held it in 3 quarters.
  • Wedbush Securities's Compugen position peaked at $58K in Q4 2021.
  • 81 funds tracked by Wall St. Rank held Compugen as of Q3 2022.

Based on Wedbush Securities's 13F filing for Q3 2022, filed 18 Oct 2022.